Lyon founders can compare genuinely different capital routes without treating every name as a local VC fund. A first B2B product, a clinically relevant health innovation and an industrial company approaching deployment need different evidence and different investors.
This guide compares 16 venture, family-office and angel routes. Seven have verified operational Lyon connections or an explicit local/regional investment remit. We separately label Angelor’s published Lyon address and the wider French or European mandates. The order helps you navigate, not rank investment performance.
Compare venture capital and angel investors for Lyon
Read the location and mandate column together. A regional office can make a conversation convenient; the investment strategy determines whether it belongs on your shortlist. On mobile, scroll the table sideways.
| Provider | Geographic connection | Stage filter | Sector fit |
|---|---|---|---|
| UI Investissement / Kreaxi | Lyon office and Auvergne-Rhône-Alpes innovation partnerships | Seed, Series A and Series B in Innovation | Deep tech, engineering, health-nutrition and digital |
| Evolem Start | Lyon base; confirm the company-specific geographic fit | Pre-seed, seed and Series A | Sector- and business-model-agnostic |
| Hi inov | Paris, Lyon and Munich presence; European B2B mandate | Confirm the current strategy’s entry stage | Enterprise software, vertical AI, infrastructure and governed data |
| HUB612 Participations | Rhône-Alpes or French-speaking Switzerland connection | Pre-seed and seed entry; follow-on capacity | B2B technology, fintech, insurtech, SaaS and AI-native products |
| Lyon Angels | Explicit Lyon-region investment area | Creation, development and company acquisition | No single sector restriction published on the founder page |
| MESH Ventures | Lyon-based; Auvergne-Rhône-Alpes operating focus | Seed and the beginning of a project | Technology-led innovation, including medtech, industrial deep tech and AI |
| Demea Sustainable Investment | Lyon office within a wider European platform | Venture and later strategies; identify the relevant fund | Energy, environment, agriculture and industrial transition |
| Angelor | Published Lyon address; French health-innovation focus | Spinout through Series A; medical and economic potential required | Healthcare innovation and clinical, industrial or commercial scale-up |
| Supernova Invest | Grenoble and Paris offices; mainly European investing | Company inception through later development; strategy-specific | Industrial technologies, healthcare, digital and cleantech |
| Axeleo Capital | France and Europe mandate; current site lists Paris | Digital pre-seed/seed; Greentech Industry Series A/B | Enterprise software and infrastructure; industrial greentech separately |
| 360 Capital | European mandate, not a Lyon-office claim | Pre-seed through Series B | Deep tech, climate tech and digital-first companies |
| Alven | Europe-wide founder focus; Paris address | Early-stage; confirm the current entry point | European technology companies; confirm sector fit |
| Serena | Europe and US scope; Paris address | Pre-seed through Series A; fund-specific | Applied AI, energy transition, data infrastructure, impact and consumer innovation |
| Newfund | French startups with global ambition and North America | Pre-seed and seed | Broad, with a published positive-impact purpose |
| Partech Seed | Europe and global seed mandate | As early as day one; separate from Venture | Broad seed remit across sectors and models |
| Karista | European mandate; no Lyon office claimed | Seed through Series B+; strategy-specific | Health, deep tech including space/defence, and digital |
Choose the evidence before choosing the investor
- First B2B software round: investigate HUB612’s accompaniment-linked route, Evolem Start, Axeleo Digital, Newfund or Partech Seed. Each has a different process and geographic test.
- Science or engineering company: compare UI Innovation, Supernova and a relevant 360 or Karista strategy. Describe the technical result, remaining risk and development milestone.
- Health innovation: Angelor’s current medical and economic criteria matter more than its name. Prepare the evidence appropriate to a device, therapeutic programme or clinical workflow.
- Industrial transition: distinguish Demea’s relevant venture vehicle from infrastructure finance and Axeleo’s Series A/B industrialisation strategy from its digital seed strategy.
- Local investors and operating relationships: research MESH and Lyon Angels with a clear explanation of the company’s regional connection. Ecosystem membership alone is not an investment commitment.
Keep our French venture-capital guide as the national comparison. This page adds Lyon-specific access, current manager names and local operating relationships rather than repeating the country list.
Sixteen investor profiles and official approach routes
1. UI Investissement / Kreaxi
Investment manager, Innovation strategy. Start with UI’s Innovation team, not its buyout proposition. Its current strategy explicitly covers seed through Series B, with engineering, deep tech, health-nutrition and digital expertise. UI publishes a Lyon office and regional innovation partnerships. Kreaxi joined the platform in 2024, so research under that older name should lead back to the current team rather than become a second prospect. Explain the technical milestone and which regional vehicle may fit.
Official investment information · Contact form; specify Innovation and the Lyon team
2. Evolem Start
Direct startup-investment arm of a family office. Evolem’s family-office structure offers a different conversation from a fixed-life venture fund. The Start arm explicitly participates from pre-seed through Series A and can lead, co-lead or follow. Describe the company’s next milestone and why this team is a relevant long-term partner. Use Start as the route: the same organisation’s property, philanthropy and established-company activities are different jobs, not additional startup investors.
Official investment information · Start team or official contact form
3. Hi inov
European B2B venture capital firm. Hi inov is relevant to a Lyon enterprise-software company because its current thesis covers specific operating problems: infrastructure intelligence, agentic enterprise tools, regulated-industry AI and trustworthy data systems. The firm names Lyon alongside Paris and Munich. Show the buyer, workflow and evidence of a meaningful product advantage. Ask about current entry-stage requirements instead of assuming that every early AI demo meets the investment threshold.
Official investment information · Start-Up option in the official contact form
4. HUB612 Participations
Direct investment vehicle connected to an accelerator. HUB612 has a direct investment vehicle, not just an acceleration programme. Its published criteria connect pre-seed and seed B2B technology with Rhône-Alpes or French-speaking Switzerland. The important process detail is that it mainly invests in companies it supports. Ask how the accompaniment and investment decisions connect. A place in an ecosystem or a portfolio support label is not the same as an equity commitment.
Official investment information · Pitcher ma startup / Candidater linked from the investment page
5. Lyon Angels
Angel-investor network. Lyon Angels explicitly identifies the Lyon region as its investment area. Its members consider creation, development and acquisition projects, with individual or joint minority investments. Prepare the ownership proposition and what member expertise could add. Follow the current entrepreneur instructions and confirm submission details before sending a file. Treat this as a network of decision-making investors, not a single guaranteed pooled cheque or an automatic introduction service.
Official investment information · Official entrepreneur instructions and dossier links; confirm current submission details
6. MESH Ventures
Regional direct startup-investment fund. MESH is the CCI Lyon Métropole Saint-Etienne Roanne investment fund. The CCI describes seed equity for technology-led companies, a regional operating focus and co-investment alongside partners. That makes it different from a general chamber-of-commerce advice service. Prepare the distinctive company insight, the local connection and the next proof point. Start with the official fund page and clarify the current founder process before sharing confidential material.
Official investment information · Official CCI fund page and linked MESH site; clarify the current founder route
7. Demea Sustainable Investment
Multi-strategy sustainable investment manager, formerly Demeter. Demea Sustainable Investment is the current name to research when older directories point to Demeter. It publishes a Lyon office and an entrepreneur-specific presentation route. Its platform spans venture capital, later company finance and infrastructure, so select the fund before building the pitch. Explain the technical or industrial risk the round will remove, and distinguish company equity from financing a project asset or borrowing.
Official investment information · Entrepreneur presentation route, entrepreneur@demea-si.com
8. Angelor
Health-focused venture manager. Angelor’s current proposition is focused on French healthcare innovation. It describes supporting companies from spinout through Series A when medical and economic potential has been demonstrated. This is not a generalist angel group despite the name. Show the medical problem, evidence and development milestone. A software-enabled clinical product, device and therapeutic programme need different proof; ask which strategy and expertise fit the actual company.
Official investment information · Entrepreneur option in the official contact form
9. Supernova Invest
Deep-tech venture manager. For a science-heavy company, a specialist team in Grenoble can be more relevant than a nearby generalist. Supernova describes mainly European deep-tech investing across industrial technology, healthcare, digital and cleantech. Its published offices are Grenoble and Paris, not Lyon. Prepare the scientific advantage, remaining technical risk and a development plan. Use the official contact to identify the right team, without assuming that a general inbox is a dedicated submission programme.
Official investment information · Published general business contact; confirm the appropriate investment team
10. Axeleo Capital
Technology venture manager with separate strategies. Axeleo illustrates why the investment strategy matters more than a familiar ecosystem label. Its Digital strategy enters at pre-seed and seed across enterprise software, AI, infrastructure and related areas. Greentech Industry enters at Series A and B around industrialisation. Both publish France and Europe scope. Use the founder address and state the relevant strategy. We do not turn older Lyon-office mentions in search results into a current office claim.
Official investment information · Published founder address, apply@axeleo.com
11. 360 Capital
European technology venture firm. 360 publishes a straightforward combination of filters: Europe, pre-seed through Series B, and deep tech, climate tech or digital-first solutions. It is a wider-mandate option for an eligible Lyon team, rather than a locally headquartered firm. Connect the product advantage to a specific next milestone. Use the public pitch route only after checking the full combination, not because one keyword matches the deck.
Official investment information · Public pitch submission form
12. Alven
Independent early-stage venture firm. Alven’s current site describes an independent early-stage firm partnering with founders in Europe. For a Lyon company, that is a broader research route rather than a local-office proposition. Lead with what the company has learned about a real customer problem and why its advantage can travel. Confirm current entry-stage and sector expectations with the team instead of filling gaps with a third-party database or one portfolio example.
Official investment information · Published contact link and business address on the official site
13. Serena
Early-stage venture platform. Serena separates its early-growth applied-AI and energy-transition strategy from pre-seed and seed themes such as infrastructure, impact and consumer innovation. Its stated geographic scope includes Europe. A Lyon founder should identify that specific strategy and the matching investment professional before asking for a conversation. The useful pitch explains which operating problem the company solves and the evidence behind it, rather than relying on a broad AI label.
Official investment information · Official investment team and published business contact; clarify the appropriate strategy
14. Newfund
First-institutional-cheque venture firm. Newfund explicitly describes first institutional money at pre-seed and seed. It considers French startups with global ambition as well as North American companies, making the geographic connection clear for a Lyon team. Prepare the founder insight, company facts and next validation milestone for its questionnaire. Use the prospective-founder application, not the portfolio login or investor subscription route. A published application process does not establish investment interest.
Official investment information · Founders: apply questionnaire
15. Partech Seed
Seed team within a multi-strategy venture platform. Partech Seed describes investing from the beginning of a company across Europe and beyond. That is a different route from Partech Venture’s Series A/B software proposition. For an early Lyon team, start with the Seed professionals and the evidence needed to move from concept to a useful product. Do not send a founder pitch to an investor-relations or press address simply because it appears on the contact page.
Official investment information · Identify the Seed investment team through the official Funds and Team pages
16. Karista
European technology venture manager. Karista gives a Lyon founder another specialist European comparison across health, deep tech and digital. Its current positioning runs from seed through later rounds, so match both the subject and the maturity of the company. Explain the technical result and the next commercial or development milestone. The official Submit your pitch page provides a founder-specific route; the breadth of its portfolio does not replace checking the relevant strategy.
Official investment information · Submit your pitch page with hosted founder form
What is venture capital?
Venture capital is investment in companies whose growth potential can justify substantial business risk. A venture investor normally receives an ownership interest, rather than simply lending money that the company repays on a schedule. Investors also evaluate whether the company’s possible growth, financing needs and eventual liquidity paths fit their strategy.
For a founder, the practical question is not whether VC is prestigious. It is whether this company needs that kind of capital to reach its next milestone. An angel network, a family-office startup arm and a venture fund can all invest in equity, but their decision makers, processes and expectations can differ. Compare those differences before spending time on a pitch.
A Lyon connection is useful, but it is not the whole investment case
HUB612 explicitly connects its investment thesis to Rhône-Alpes or French-speaking Switzerland and explains how accompaniment relates to investment. MESH’s official CCI description identifies a Lyon base and a regional technology focus. UI and Demea publish actual Lyon offices. Those are different kinds of local evidence, not interchangeable eligibility promises.
Wider funds can still be relevant. Newfund explicitly considers French startups with global ambition; 360 and Karista describe European mandates. Conversely, an old search-result snippet can outlive an office or strategy. We use current official information and keep unknown criteria visible. Rebrands are reconciled: UI/Kreaxi counts once, as does Demea and its earlier Demeter name.
A Lyon software team turns six names into three next actions
Fictional example, not a funding recommendation. Two Lyon founders have an AI-assisted maintenance-planning product, a working prototype and one paid industrial pilot. They need capital to test onboarding with additional customers. They are not developing a medical product or constructing an energy-generation asset.
| Candidate | Decision | Next question |
|---|---|---|
| HUB612 Participations | Investigate the local B2B route | How does accompaniment connect to an investment decision? |
| Axeleo Digital | Research the software entry point | What product and buyer evidence would support a seed discussion? |
| Evolem Start | Prepare an evidence-led introduction | Does this milestone and founder proposition fit the current team? |
| Hi inov | Clarify before approaching | Does the current strategy consider this maturity of industrial software? |
| Axeleo Greentech Industry | Hold this specific strategy | The example is not yet the Series A/B industrialisation case described. |
| Angelor | Exclude for this company | No health-innovation fit, despite a local address. |
The output is three focused next actions, one stage question, one hold and one exclusion. It is more useful than sending six versions of the same generic deck. No investor interest is implied.
Build your Lyon investor-fit worksheet
Copy one card per investor family. Keep the official source and research date beside your decision so your cofounder can see why the provider is on the list.
LYON INVESTOR FIT CARD
Company and next milestone: [what the round should prove]
Current evidence: [prototype / technical result / pilot / repeatable revenue]
Manager and strategy: [current name; relevant vehicle or team]
Connection: [Lyon office / regional mandate / published address / wider scope]
Official criteria and date: [URL; stage; sector; geographic conditions]
Process: [direct fund / angel members / accompaniment-linked investment]
Approach route: [founder form / investment team / general enquiry to clarify]
Open question: [what must be confirmed before sharing a deck]
Decision and owner: [research / clarify / approach / hold; accountable person]
Next action and date: [specific, reviewed next move]Bring the shortlist, evidence links and next actions into Finta. Review who knows whom, prepare a relevant request or public submission, and keep the conversation connected to the company milestone. Aurora can help organise the comparison and prepare your next questions.
Research the next step with Aurora, Claude or Codex
Help me evaluate investor fit for a Lyon startup.
Company, current evidence and next milestone: [authorised facts]
Candidates and official sources: [paste a small shortlist]
Compare stage, sector, geography and the relevant fund or team.
Separate an operational Lyon office, regional remit and wider mandate.
Distinguish direct equity, angel-member decisions and accelerator support.
Reconcile renamed managers and related fund brands so they count once.
Identify the verified founder route; label general contacts honestly.
Return source/date, fit evidence, open question, decision and next action.
Do not infer available allocation or investor interest from a portfolio logo.
Do not contact anyone, submit a form or share confidential material.Continue with the investor-prospecting workflow, warm-introduction requests and the Seed Fundraising Comprehensive Guide.
Methodology and research date
By Finta Editorial Team. Official investment, strategy and founder-contact sources reviewed November 12, 2026. We selected actual investment managers, direct vehicles and an angel network, not programmes that only advise founders. Seven entries have a verified operational Lyon connection or explicit local/regional remit; Angelor’s published legal address is labelled separately. Wider mandates do not imply a local office.
Providers count once after reconciling related managers and rebrands. The table is a research aid, not a performance ranking or an exhaustive directory. Confirm current company requirements and investment capacity directly. No cheque sizes, response-time promises or expected investment returns are inferred. This is general information, not personalised financial, legal or tax advice.
The cover illustrates the meeting of the Rhône and Saône, with health research, enterprise-software and industrial-transition clusters. It is an ecosystem concept, not a map of investor offices.